Disclosed is a topical skin composition comprising a glycol di-salicylate or a glycol di-benzoate compound having the following structure:where R is OH or H, n is 1 or 2, and where the composition further includes a glycol mono-salicylate compound or a glycol mono-benzoate compound.
